Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

Diego Villa*, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J. Buege, Anita Kumar, David A. Bond, Jonas Paludo, Matthew J. Maurer, Gita Thanarajasingam, Katharine L. Lewis, Chan Y. Cheah, Joachim Baech, Tarec C. El Galaly, Laveniya Kugathasan, David W. Scott, Alina S. Gerrie, David Lewis

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

3 Citations (Scopus)
11 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry